Skip to main content
. 2020 Jan 16;4(2):253–262. doi: 10.1182/bloodadvances.2019000875

Table 3.

Comparison between outcomes of patients with LS-DHL treated with R-CHOP vs IIC

All DHL patients, N = 40 R-CHOP, N = 16 IIC, N = 24 P
ORR, n (%) 34 (85) 13 (81) 21 (88) .67
CR, n (%) 30 (75) 10 (63) 20 (83) .16
PR, n (%) 4 (10) 3 (19) 1 (4) .28
2-y PFS, % 74 75 74 .85
2-y OS, % 81 81 81 1.00